Why Protein Design Has Outpaced Small Molecule AI Modeling
Source: Drug Discovery Online
Protein design has advanced faster than small‑molecule AI because proteins are built from a limited alphabet and benefit from rich public datasets like the PDB. Small‑molecule modeling faces a much larger chemical space and far less openly available data, much of which remains tied to proprietary pharma programs.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online